Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Point72 Asset Management, L.P. reported a 5.00% stake in Cytomx Therapeutics, Inc. (Schedule 13G)
Event Apr 15, 2026 · Filed Apr 16, 2026
Point72 Asset Management, L.P. reported a 5.00% stake in Cytomx Therapeutics, Inc., 10,864,581 shares, as a passive investor on Apr 15, 2026. Filed Apr 16, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 10,864,581
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.00% | 10,864,581 |
| Point72 Capital Advisors, Inc. | 5.00% | 10,864,581 |
| Steven A. Cohen | 5.00% | 10,864,581 |
Source
Related
- Cytomx Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Nov 14, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2025
- Schedule 13G · Point72 Asset Management, L.P. · May 14, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026